CRISPR Therapeutics AG (CRSP)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

BAARERSTRASSE 14 ZUG, SWITZERLAND CH-6300

CRISPR Therapeutics AG is a bio-technology company. The Company researches, develops, and manufactures biological transformative gene-based medicines and other related products. CRISPR Therapeutics operates in Switzerland.

Data as of 2021-05-08 11:48:20 -0400
Market Cap8.16 Billion Shares Outstanding75.769 Million Avg 30-day Volume1.569 Million
P/E Ratio-20.80137 Dividend Yield EPS-5.65
Price/Sales7411.73 Debt to Equity1.08 EBITDA-385.584 Million
Price to Book Value4.52 Forward PE-17.7 Enterprise Value6.354 Billion
Total Cash1.806 Billion Current Debt83.09 Million Gross Profit1.101 Million
BETA1.25545 52-week High/Low220.2 / 54.0 Next Earnings Date2021-07-27 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from CRSP instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 9 -44.44% 2 (0.12%) 3 (0.19%) -33.33%
Funds Holding: 398 301 32.23% 86 (5.17%) 70 (4.36%) 22.86%
13F shares: 47.09 Million 47.354 Million -0.56% 19.852 Million 20.214 Million -1.79%
% Ownership 66.1314 67.0232 -1.33% 27.8787 28.6105 -2.56%
New Positions: 135 68 98.53% 28 12 133.33%
Increased Positions 127 93 36.56% 27 21 28.57%
Closed Positions 37 31 19.35% 13 12 8.33%
Reduced Positions 88 86 2.33% 23 25 -8.0%
Total Calls 1.86 Million 753.344 Thousand 146.89% 360 Thousand 158.7 Thousand 126.84%
Total Puts 1.784 Million 737.079 Thousand 142.01% 384.925 Thousand 259.425 Thousand 48.38%
PUT/CALL Ratio 0.96 0.98 -2.04% 1.07 1.63 -34.36%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CRSP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CRSP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

130.4 Thousand total shares from 9 transactions

Exercise Derivative Conversion (M)

88 Thousand total shares from 6 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KLEIN LAWRENCE OTTO CBO & COO

  • Officer
122,716 2021-03-23 7

BOLZON BRADLEY J PHD

  • Director
1,585,335 2021-03-22 17

KULKARNI SAMARTH CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
324,498 2021-03-10 10

KASINGER JAMES R. GENERAL COUNSEL AND SECRETARY

  • Officer
58,271 2021-03-10 4

HO TONY W EXECUTIVE VP, HEAD OF R&D

  • Officer
70,638 2021-03-10 6

TOMSICEK MICHAEL JOHN CHIEF FINANCIAL OFFICER

  • Officer
36,251 2021-03-10 4

NOVAK RODGER PRESIDENT

  • Officer
  • Director
648,007 2020-11-30 9

BEHBAHANI ALI

  • Director
270 2020-08-13 2

GEORGE SIMEON

  • Director
0 2020-06-11 1

GREENE JOHN

  • Director
0 2020-06-11 1

HIGH KATHERINE A

  • Director
0 2020-06-11 1

TRECO DOUGLAS A

  • Director
0 2020-06-11 2

CAGNONI PABLO J

  • Director
0 2019-11-19 0

VERTEX PHARMACEUTICALS (EUROPE) LTD

VERTEX PHARMACEUTICALS INC / MA

  • 10% Owner
5,380,940 2018-12-26 0

EMSTER KURT VON

  • Director
1,171,268 2018-12-18 0

WOIWODE THOMAS

  • Director
0 2018-06-15 0

VERSANT VENTURE CAPITAL V, L.P.

VERSANT VENTURES V, LLC

VERSANT AFFILIATES FUND V, L.P.

VERSANT OPHTHALMIC AFFILIATES I, L.P.

VERSANT VENTURE CAPITAL V (CANADA), LP

  • 10% Owner
1,729,151 2018-04-24 0

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT SIDE FUND IV, L.P.

VERSANT VENTURES IV, LLC

VERSANT VENTURE CAPITAL V, L.P.

VERSANT AFFILIATES FUND V, L.P.

VERSANT OPHTHALMIC AFFILIATES I, L.P.

VERSANT VENTURE CAPITAL V (CANADA), LP

  • 10% Owner
4,004,248 2018-04-20 0

DYLAN-HYDE TYLER CHIEF LEGAL OFFICER

  • Officer
25,204 2018-01-16 0

BAYER AKTIENGESELLSCHAFT

BAYER GLOBAL INVESTMENTS B.V.

  • 10% Owner
5,708,747 2018-01-05 0

CELGENE CORP /DE/

  • 10% Owner
No longer subject to file 2017-11-03 0

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT SIDE FUND IV, L.P.

VERSANT VENTURE CAPITAL V, L.P.

VERSANT AFFILIATES FUND V, L.P.

VERSANT OPHTHALMIC AFFILIATES I, L.P.

VERSANT VENTURE CAPITAL V (CANADA), LP

VERSANT VENTURES IV, LLC

VERSANT VENTURES V, LLC

VERSANT VENTURES V (CANADA), L.P.

  • 10% Owner
4,606,242 2017-09-05 0

SUBRAMANIAN KALA SEE REMARKS

  • Officer
0 2017-06-15 0

COLES N ANTHONY

  • Director
0 2017-05-31 0

LUNDBERG SVEN ANTE CHIEF SCIENTIFIC OFFICER

  • Officer
1,010,834 2016-10-24 0

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT SIDE FUND IV, L.P.

VERSANT VENTURE CAPITAL V, L.P.

VERSANT AFFILIATES FUND V, L.P.

VERSANT OPHTHALMIC AFFILIATES I, L.P.

VERSANT VENTURE CAPITAL V (CANADA), LP

  • 10% Owner
6,909,347 2016-10-24 0

HADLEY HARBOR MASTER INVESTORS (CAYMAN) L.P.

  • 10% Owner
No longer subject to file 2016-10-24 0

GLAXOSMITHKLINE PLC

  • 10% Owner
3,220,627 2016-10-24 0

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT SIDE FUND IV, L.P.

VERSANT VENTURE CAPITAL V, L.P.

VERSANT VENTURE CAPITAL V (CANADA), LP

  • 10% Owner
6,758,169 2016-10-24 0

BECKER MARC CHIEF FINANCIAL OFFICER

  • Officer
0 2016-10-18 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

KLEIN LAWRENCE OTTO - Officer CBO & COO

2021-03-25 17:39:52 -0400 2021-03-23 M 12,000 d 43,000 direct

KLEIN LAWRENCE OTTO - Officer CBO & COO

2021-03-25 17:39:52 -0400 2021-03-23 M 22,000 d 38,000 direct

KLEIN LAWRENCE OTTO - Officer CBO & COO

2021-03-25 17:39:52 -0400 2021-03-23 S 12,000 $126.97 d 1,050 direct yes -0.4675 9.6638 9.6638 6 -0.4675 2

KLEIN LAWRENCE OTTO - Officer CBO & COO

2021-03-25 17:39:52 -0400 2021-03-23 M 12,000 $14.43 a 89,050 direct -0.4675 9.6638 9.6638 6 -0.4675 2

KLEIN LAWRENCE OTTO - Officer CBO & COO

2021-03-25 17:39:52 -0400 2021-03-23 M 22,000 $51.49 a 47,050 direct -0.4675 9.6638 9.6638 6 -0.4675 2

KLEIN LAWRENCE OTTO - Officer CBO & COO

2021-03-25 17:39:52 -0400 2021-03-23 M 20,000 d 25,000 direct

KLEIN LAWRENCE OTTO - Officer CBO & COO

2021-03-25 17:39:52 -0400 2021-03-23 M 12,000 d 3,000 direct

KLEIN LAWRENCE OTTO - Officer CBO & COO

2021-03-25 17:39:52 -0400 2021-03-23 S 88,000 $128.20 d 13,050 direct yes -0.4675 9.6638 9.6638 6 -0.4675 2

KLEIN LAWRENCE OTTO - Officer CBO & COO

2021-03-25 17:39:52 -0400 2021-03-23 M 20,000 $40.87 a 77,050 direct -0.4675 9.6638 9.6638 6 -0.4675 2

KLEIN LAWRENCE OTTO - Officer CBO & COO

2021-03-25 17:39:52 -0400 2021-03-23 M 12,000 $44.67 a 25,050 direct -0.4675 9.6638 9.6638 6 -0.4675 2

KLEIN LAWRENCE OTTO - Officer CBO & COO

2021-03-25 17:39:52 -0400 2021-03-23 M 10,000 d 10,000 direct

KLEIN LAWRENCE OTTO - Officer CBO & COO

2021-03-25 17:39:52 -0400 2021-03-23 M 12,000 d 2,666 direct

KLEIN LAWRENCE OTTO - Officer CBO & COO

2021-03-25 17:39:52 -0400 2021-03-23 M 12,000 $17.66 a 101,050 direct -0.4675 9.6638 9.6638 6 -0.4675 2

KLEIN LAWRENCE OTTO - Officer CBO & COO

2021-03-25 17:39:52 -0400 2021-03-23 M 10,000 $29.87 a 57,050 direct -0.4675 9.6638 9.6638 6 -0.4675 2

BOLZON BRADLEY J PHD - Director

2021-03-24 18:00:11 -0400 2021-03-22 S 3,600 $129.36 d 57,149 direct yes -2.9319 4.1972 -6.0209 18.4293 22 -6.0209 31

BOLZON BRADLEY J PHD - Director

2021-03-24 18:00:11 -0400 2021-03-22 S 5,237 $134.33 d 30,675 direct yes -2.9319 4.1972 -6.0209 18.4293 22 -6.0209 31

BOLZON BRADLEY J PHD - Director

2021-03-24 18:00:11 -0400 2021-03-22 S 2,400 $131.14 d 51,336 direct yes -2.9319 4.1972 -6.0209 18.4293 22 -6.0209 31

BOLZON BRADLEY J PHD - Director

2021-03-24 18:00:11 -0400 2021-03-22 S 9,334 $133.28 d 35,912 direct yes -2.9319 4.1972 -6.0209 18.4293 22 -6.0209 31

BOLZON BRADLEY J PHD - Director

2021-03-24 18:00:11 -0400 2021-03-22 S 3,413 $130.42 d 53,736 direct yes -2.9319 4.1972 -6.0209 18.4293 22 -6.0209 31

BOLZON BRADLEY J PHD - Director

2021-03-24 18:00:11 -0400 2021-03-22 S 300 $134.93 d 30,375 direct yes -2.9319 4.1972 -6.0209 18.4293 22 -6.0209 31

BOLZON BRADLEY J PHD - Director

2021-03-24 18:00:11 -0400 2021-03-22 S 6,090 $132.53 d 45,246 direct yes -2.9319 4.1972 -6.0209 18.4293 22 -6.0209 31

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CRISPR THERAPEUTICS AG CRSP 2021-05-10 22:15:04 UTC -0.2 0.25 950000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 21:45:02 UTC -0.2 0.25 950000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 21:15:02 UTC -0.2 0.25 950000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 20:45:03 UTC -0.2 0.25 950000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 20:15:03 UTC -0.2 0.25 950000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 19:45:03 UTC -0.2 0.25 950000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 19:15:03 UTC -0.2 0.25 950000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 18:45:03 UTC -0.2 0.25 950000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 18:15:03 UTC -0.2 0.25 950000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 17:45:02 UTC -0.2 0.25 950000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 17:15:03 UTC -0.2 0.25 950000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 16:45:03 UTC -0.2 0.25 950000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 16:15:03 UTC -0.2 0.25 950000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 15:45:03 UTC -0.2 0.25 700000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 15:15:03 UTC -0.2 0.25 700000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 14:45:04 UTC -0.2055 0.2555 700000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 14:15:04 UTC -0.2055 0.2555 700000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 13:45:04 UTC -0.2055 0.2555 700000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 13:15:03 UTC -0.2055 0.2555 700000
CRISPR THERAPEUTICS AG CRSP 2021-05-10 12:45:02 UTC -0.2055 0.2555 700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments